Cancer Clinical Trial
— E²-RADIatEOfficial title:
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
NCT number | NCT03818503 |
Other study ID # | EORTC-1811 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | June 24, 2019 |
Est. completion date | April 30, 2024 |
The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.
Status | Recruiting |
Enrollment | 2000 |
Est. completion date | April 30, 2024 |
Est. primary completion date | April 30, 2024 |
Accepts healthy volunteers | |
Gender | All |
Age group | 12 Years and older |
Eligibility | Inclusion Criteria: - Pathologically confirmed cancer. - Written informed consent for E²-RADIatE according to applicable legal and ethical requirements - Planned use of radiotherapy - Eligibility of the patient confirmed for at least one cohort confirmed - Patients of 12 years and older |
Country | Name | City | State |
---|---|---|---|
Austria | Medical University of Graz - Radio-oncology | Graz | |
Austria | Ordensklinikum Linz-Barmherzige Schwestern | Linz | |
Austria | Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken | Vienna | |
Belgium | Onze Lieve Vrouw Ziekenhuis | Aalst | |
Belgium | Cliniques Universitaires Saint-Luc | Brussels | |
Belgium | Universitair Ziekenhuis Gent | Gent | |
Belgium | AZ Groeninge Kortrijk - Campus Kennedylaan | Kortrijk | |
Belgium | U.Z. Leuven - Campus Gasthuisberg | Leuven | |
Belgium | CHU Site Sainte-Elisabeth-UCL Namur | Namur | |
Belgium | AZ Turnhout - Campus Sint Elisabeth | Turnhout | |
Belgium | GasthuisZusters Antwerpen - Sint-Augustinus | Wilrijk | |
Czechia | University Hospital Hradec Kralove | Hradec Kralove | |
France | Clinique Pasteur-Lanroze (1174) | Brest | |
Germany | Universitaetsklinikum Aachen AOR - Medizinische Fakultaet der RWTH | Aachen | |
Germany | Klinikum Bayreuth Gmbh | Bayreuth | |
Germany | Universitaetsklinikum Carl Gustav Carus | Dresden | |
Italy | Ospedale S. Donato, USL -8 | Arezzo | |
Italy | Azienda Ospedaliero-Universitaria Careggi | Firenze | |
Italy | Istituto Clinico Humanitas | Milan | |
Italy | IRCCS Ospedale San Raffaele | Milano | |
Italy | Istituto Europeo di Oncologia | Milano | |
Italy | Sacro Cuore Hospital | Negrar | |
Italy | Centro Nazionale di Adroterapia Oncoloica par il trattamento dei tumori | Pavia | |
Italy | Istituti Clinici Scientifici Maugeri | Pavia | |
Italy | Policlinico Universitario Campus Bio-Medico- Oncology Center | Roma | |
Italy | Universita Di Torino | Torino | |
Netherlands | Stichting Catharina Ziekenhuis | Eindhoven | |
Netherlands | Radboudumc - Radboud University Medical Center Nijmegen | Nijmegen | |
Netherlands | Radiotherapiegroep Arnhem | Nijmegen | |
Slovenia | The Institute Of Oncology | Ljubljana | |
Spain | ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) | Badalona | |
Spain | Hospital De La Santa Creu I Sant Pau | Barcelona | |
Spain | Hospital Universitari Vall d'Hebron -Vall d'Hebron Institut Oncologia | Barcelona | |
Spain | Hospital General Universitario Santa Lucia | Cartagena | |
Spain | Hospital Universitario Reina Sofia | Cordoba | |
Spain | Hospital Universitario de La Princesa | Madrid | |
Spain | Hospital Universitario San Carlos | Madrid | |
Spain | Complejo Hospitalario de Navarra | Pamplona | |
Spain | Hospital Universitario de Salamanca (430) | Salamanca | |
Spain | Hospital Universitario La Fe | Valencia | |
Switzerland | Inselspital | Bern | |
Switzerland | Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie | Geneve | |
Switzerland | Reseau Hospitalier Neuchatelois - RHNe - La Chaux de Fonds | La Chaux-de-Fonds | |
Switzerland | Hopital du Valais - Hopital de Sion | Sion | |
Switzerland | UniversitaetsSpital Zurich | Zürich | |
United Kingdom | NHS Grampian - Aberdeen Royal Infirmary | Aberdeen | |
United Kingdom | The Christie NHS Foundation trust - The Christie NHS Foundation Trust | Manchester | |
United Kingdom | Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital | Sheffield |
Lead Sponsor | Collaborator |
---|---|
European Organisation for Research and Treatment of Cancer - EORTC |
Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Slovenia, Spain, Switzerland, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of patients treated with radiotherapy enrolled in the program | 5 years | ||
Secondary | Disease free survival | 5 years | ||
Secondary | Loco-regional control | 5 years | ||
Secondary | Distant metastasis free survival | 5 years | ||
Secondary | Overall survival | 5 years | ||
Secondary | Incidence of adverse events related to radiotherapy | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|